SLC39A14 and Parkinson disease: By six months of age, Slc39a14−/− mice began to show signs of dystonia with a progressive inability to coordinate their motor activity (Figure 1c–i); these symptoms are similar to the PD-like motor disability in patients with a mutation in SLC39A14 [4].